Alumis ALMS
NASDAQ ALMS
$6.40 -0.15 (-2.29%)
At close: Nov 10, 2026 · 4:00 PM EST

Alumis (ALMS) Net Margin (2025 - 2026)

Updated

Alumis (ALMS) reported Net Margin of -8557.22% for Q2 2026, down 10782.31 percentage points from 2225.09% a year earlier.

Analysis

Alumis (ALMS) Net Margin (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Alumis' Net Margin came in at -3443.77%; for FY2025, it was -1011.75%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.83%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.24%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 28.01%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 20.69%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 37.28%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 29.27%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 19.55%
10 Alumis 796.45 Mn -915.01 Mn - -8,557.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8,557.22%
Mar 31, 2026 -5,344.80%
Dec 31, 2025 -4,817.26%
Sep 30, 2025 -5,363.02%
Jun 30, 2025 2,226.22%
Mar 31, 2025 -569.11%
API Access

Alumis Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=ALMS&period=max&api_key=YOUR_API_KEY